Understanding The Potential of CYB561D1 as A Drug Target (G284613)

Target Name: CYB561D1

NCBI ID: G284613

CYB561D1

Understanding The Potential of CYB561D1 as A Drug Target

CYB561D1 is a protein that is expressed in a wide range of tissues and cells in the human body. It is a member of the cytochrome b561 gene family, which is known for its role in the function of cytochrome P450 enzymes. These enzymes are involved in the metabolism of a wide variety of drugs and other molecules, and are often targeted by drug developers as potential drug targets.

One of the unique features of CYB561D1 is its expression pattern. It is highly expressed in the liver, and is also expressed in other organs and tissues, including the heart, the kidneys, and the lungs. It is also found in the blood and the lymph fluid. These observations suggest that CYB561D1 may be a useful biomarker for monitoring the effectiveness of drugs that target this protein.

In addition to its expression pattern, CYB561D1 is also known for its unique structure. It is a 125 amino acid protein with a calculated molecular mass of 13.9 kDa. It has a single transmembrane domain and a calculated pI of 7.4. These features make it a unique protein that is well-suited for study as a drug target.

The study of CYB561D1 has been ongoing for several years, and there is a growing body of research that is focused on its potential as a drug target. One of the main areas of focus is the study of its role in drug metabolism. Many drugs are metabolized by the cytochrome b561 gene family, and it is thought that CYB561D1 may be involved in this process.

In addition to its role in drug metabolism, CYB561D1 is also being studied for its potential as a therapeutic target. One of the main ideas behind this research is that drugs that target CYB561D1 may be able to inhibit its activity, which could be useful for treating a wide range of diseases. For example, some studies have suggested that CYB561D1 may be involved in the development of cancer, and that inhibiting its activity may be a potential therapy for this disease.

Another area of research is the study of CYB561D1's role in the immune system. It is thought that CYB561D1 may be involved in the regulation of immune responses, and that its activity may be influenced by factors such as inflammation and infection. This suggests that CYB561D1 may be a potential target for drugs that are designed to enhance or inhibit the immune system.

In conclusion, CYB561D1 is a protein that is expressed in a wide range of tissues and cells in the human body. It is a member of the cytochrome b561 gene family and has a unique structure that makes it well-suited for study as a drug target. The study of CYB561D1 has been ongoing for several years and there is a growing body of research that is focused on its potential as a drug target and its role in the immune system. Further studies are needed to fully understand its potential as a therapeutic agent.

Protein Name: Cytochrome B561 Family Member D1

Functions: Probable transmembrane reductase that may use ascorbate as an electron donor and transfer electrons across membranes to reduce monodehydro-L-ascorbate radical and iron cations Fe(3+) in another cellular compartment

The "CYB561D1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYB561D1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets